Yu S, Schwab PE, Bian B, Nero D, Radican L, Tunceli K, Qui Y. Treatment patterns of type 2 diabetes mellitus patients on metformin monotherapy with suboptimal glycemic control: a U.S. database study. Poster presented at the 2013 International Diabetes Federation World Diabetes Congress; December 2, 2013. Melbourne, Australia.
Bhattacharyya S, Sacco P, Shirore R, Sonathi V, Thomas SK. A de novo economic model to assess the cost and quality of life consequences of an intervention for levodopa induced dyskinesia amongst patients with Parkinson's disease. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A590-1.
Schwab PE, Zhou Y, Stemkowski S, Barbato L, Zacker C. Analysis of first dose observation data for MS treatment with fingolimod (DX14). Poster presented at the 2013 Consortium for Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis 5th Cooperative Meeting; May 29, 2013. Orlando, FL.
Xe Y, Bays H, Schwab PE, Louder A. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presented at the 2013 American Heart Association Quality of Care and Outcomes Research (AHA QCOR) Scientific Sessions; May 15, 2013. Baltimore, MD.
Xe Y, Bays H, Schwab PE, Louder A. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 18, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A295. doi: 10.1016/j.jval.2013.03.1529
Harris J, Ward M, Schwab PE. Adherence to HCV RNA laboratory monitoring guidelines and futility rules in protease inhibitor based triple therapy for the treatment of chronic HCV genotype 1 infection. Poster presented at the 2013 Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo; April 2, 2013. CA.
Lennert B, Farrelly E, Sacco P, Pira G, Frost M. Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study. J Child Neurol. 2013 Apr;28(4):461-9.
Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.
Thase MF, Fava M, Hollander S, Simmons JH, Ivgy-May N, Boyle K, Gibertini M. Analysis of the effects of gepirone-ER on the Bech-6 and individual HAM-D 17-item scores. Poster presented at the 2003 42nd ACNP Annual Meeting; December 2003. San Juan, Puerto Rico.
Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.
Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.